Literature DB >> 33725855

Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Qiumei Zhou1, Yulong Wang2, Jiajia Wang3, Yating Liu4, Dehui Qi5, Wei Yao1, Hui Jiang1, Tingting Li4, Kaiquan Huang1, Wancun Zhang6, Xingxing Huo1.   

Abstract

ABSTRACT: Although non-alcoholic fatty liver disease (NAFLD) is strongly associated with type 2 diabetes mellitus (T2DM), the diagnosis of NAFLD for T2DM patients remains a challenge.This study aimed to investigate the prevalence and risk factors for the NAFLD in T2DM outpatients.This is a retrospective, cross-sectional study that included 2405 T2DM patients treated and admitted for glucose control into the Endocrinology Department of our hospital from April 2017 to March 2019. Using strict exclusion criteria, the target patients were screened and divided into two groups: NAFLD patients (study group) and non-NAFLD patients (control group). Subsequently, 34 factors were compared between the two groups. Furthermore, multivariate analysis of the NAFLD risk factors was performed using logistic regression. Finally, the diagnostic significance of individual biochemical predictors, as well as the combined predictive indicator (CPI), for NAFLD was estimated using receiver operating characteristic (ROC) curve analysis.In this study, the overall prevalence of NAFLD in T2DM patients was 58.67%. Of the target patients, 17 factors were identified by univariate analysis to be associated with NAFLD, and 8 factors were found to be significant predictors for NAFLD using binary logistic regression modeling. Furthermore, the CPI and C-Peptide represent high diagnostic value for NAFLD in T2DM patients.This study provides a more comprehensive risk factor analysis for NAFLD in T2DM patients. These data can be used to provide timely diagnosis and effective management of NAFLD.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33725855      PMCID: PMC7969325          DOI: 10.1097/MD.0000000000024940

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  38 in total

1.  Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.

Authors:  Israt Ara Hossain; Md Mijanur Rahman Shah; Mohammad Khalilur Rahman; Liaquat Ali
Journal:  Diabetes Metab Syndr       Date:  2015-10-09

2.  Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.

Authors:  Alessandro Mantovani; Giorgio Grani
Journal:  Dig Dis Sci       Date:  2018-04-19       Impact factor: 3.199

Review 3.  Non-alcoholic fatty liver disease - A global public health perspective.

Authors:  Zobair M Younossi
Journal:  J Hepatol       Date:  2018-11-09       Impact factor: 25.083

4.  A combination of raised serum AST:ALT ratio and erythrocyte mean cell volume level detects excessive alcohol consumption.

Authors:  I Kawachi; G M Robinson; N H Stace
Journal:  N Z Med J       Date:  1990-04-11

5.  Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.

Authors:  I Doycheva; J Cui; P Nguyen; E A Costa; J Hooker; H Hofflich; R Bettencourt; S Brouha; C B Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2015-09-15       Impact factor: 8.171

6.  Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.

Authors:  M Yi; R-P Chen; R Yang; H Chen
Journal:  Diabet Med       Date:  2016-09-15       Impact factor: 4.359

7.  Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study.

Authors:  Yuichiro Takeuchi; Hiroyuki Ito; Yuko Komatsu; Koshiro Oshikiri; Shinichi Antoku; Mariko Abe; Mizuo Mifune; Michiko Togane
Journal:  Intern Med       Date:  2012-07-01       Impact factor: 1.271

8.  The relationship between normal serum uric acid and nonalcoholic fatty liver disease.

Authors:  In-Cheol Hwang; Sang-Yeon Suh; Ah-Ram Suh; Hong-Yup Ahn
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

9.  Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study.

Authors:  Masood Sepehrimanesh; Ramin Niknam; Fardad Ejtehadi; Mohammad Reza Fattahi; Alireza Safarpour
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-01       Impact factor: 3.168

10.  Abdominal obesity in German adolescents defined by waist-to-height ratio and its association to elevated blood pressure: the KiGGS study.

Authors:  Katrin Kromeyer-Hauschild; Hannelore Neuhauser; Angelika Schaffrath Rosario; Anja Schienkiewitz
Journal:  Obes Facts       Date:  2013-04-12       Impact factor: 3.942

View more
  1 in total

1.  Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.

Authors:  Conghui Guan; Songbo Fu; Donghu Zhen; Kuan Yang; Jinyang An; Yapei Wang; Chengxu Ma; Na Jiang; Nan Zhao; Jinjin Liu; Fang Yang; Xulei Tang
Journal:  J Diabetes Res       Date:  2022-01-28       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.